News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cenix BioScience GmbH Expands Relationship with AstraZeneca AB, Signing Multi-Project Research Agreement


6/15/2009 8:56:29 AM

DRESDEN, Germany--(BUSINESS WIRE)--Cenix BioScience GmbH, a leading RNA interference (RNAi)-focused contract research organization, today announced that they have signed a new multi-project research agreement with AstraZeneca, thereby expanding their relationship beyond its initial oncology focus, to now include respiratory and inflammation-related indications.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES